BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29231066)

  • 1. Synthesis and characterisation of celastrol derivatives as potential anticancer agents.
    Zhang HJ; Zhang GR; Piao HR; Quan ZS
    J Enzyme Inhib Med Chem; 2017 Dec; 33(1):190-198. PubMed ID: 29231066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of celastrol derivatives as anticancer agents.
    Tang WJ; Wang J; Tong X; Shi JB; Liu XH; Li J
    Eur J Med Chem; 2015 May; 95():166-73. PubMed ID: 25812966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of novel C-29 carbamate celastrol derivatives as potent and selective cytotoxic compounds.
    Figueiredo SAC; Salvador JAR; Cortés R; Cascante M
    Eur J Med Chem; 2017 Oct; 139():836-848. PubMed ID: 28865279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Biological Evaluation of a Series of Novel Celastrol Derivatives with Amino Acid Chain.
    Pang C; Luo J; Liu C; Wu X; Wang D
    Chem Biodivers; 2018 May; 15(5):e1800059. PubMed ID: 29633499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
    Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
    Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel celastrol derivatives with improved selectivity and enhanced antitumour activity: Design, synthesis and biological evaluation.
    Figueiredo SAC; Salvador JAR; Cortés R; Cascante M
    Eur J Med Chem; 2017 Sep; 138():422-437. PubMed ID: 28688281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and antitumor evaluation of novel celastrol derivatives.
    Xu M; Li N; Zhao Z; Shi Z; Sun J; Chen L
    Eur J Med Chem; 2019 Jul; 174():265-276. PubMed ID: 31051401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel oleanolic acid and ursolic acid in C-28 position derivatives as potential anticancer agents.
    Tian T; Liu X; Lee ES; Sun J; Feng Z; Zhao L; Zhao C
    Arch Pharm Res; 2017 Apr; 40(4):458-468. PubMed ID: 28101738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3).
    Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV
    Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro antitumor evaluation of betulin acid ester derivatives as novel apoptosis inducers.
    Yang SJ; Liu MC; Xiang HM; Zhao Q; Xue W; Yang S
    Eur J Med Chem; 2015 Sep; 102():249-55. PubMed ID: 26280921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety.
    Liu MC; Yang SJ; Jin LH; Hu DY; Xue W; Song BA; Yang S
    Eur J Med Chem; 2012 Dec; 58():128-35. PubMed ID: 23124210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and anticancer evaluation of novel quinoline derivatives of ursolic acid with hydrazide, oxadiazole, and thiadiazole moieties as potent MEK inhibitors.
    Jin XY; Chen H; Li DD; Li AL; Wang WY; Gu W
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):955-972. PubMed ID: 31072147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one-linked to triazole moieties as potent cytotoxic agents.
    Liu CF; Shen QK; Li JJ; Tian YS; Quan Z
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1111-1119. PubMed ID: 28791908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitumor activity of ring A modified 11-keto-β-boswellic acid derivatives.
    Csuk R; Niesen-Barthel A; Schäfer R; Barthel A; Al-Harrasi A
    Eur J Med Chem; 2015 Mar; 92():700-11. PubMed ID: 25618017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
    Yang X; Li Y; Jiang W; Ou M; Chen Y; Xu Y; Wu Q; Zheng Q; Wu F; Wang L; Zou W; Zhang YJ; Shao J
    Chem Biol Drug Des; 2015 Dec; 86(6):1397-404. PubMed ID: 26077799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents.
    Hua SX; Huang RZ; Ye MY; Pan YM; Yao GY; Zhang Y; Wang HS
    Eur J Med Chem; 2015 May; 95():435-52. PubMed ID: 25841199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New phosphate derivatives of betulin as anticancer agents: Synthesis, crystal structure, and molecular docking study.
    Chrobak E; Kadela-Tomanek M; Bębenek E; Marciniec K; Wietrzyk J; Trynda J; Pawełczak B; Kusz J; Kasperczyk J; Chodurek E; Paduszyński P; Boryczka S
    Bioorg Chem; 2019 Jun; 87():613-628. PubMed ID: 30947097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological activity of 1,4-quinone moiety attached to betulin derivatives as potent DT-diaphorase substrate.
    Kadela-Tomanek M; Jastrzębska M; Marciniec K; Chrobak E; Bębenek E; Latocha M; Kuśmierz D; Boryczka S
    Bioorg Chem; 2021 Jan; 106():104478. PubMed ID: 33272711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and Anticancer Evaluation of Novel Indole Derivatives of Ursolic Acid as Potential Topoisomerase II Inhibitors.
    Li AL; Hao Y; Wang WY; Liu QS; Sun Y; Gu W
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and Synthesis of Novel Dehydroepiandrosterone Analogues as Potent Antiproliferative Agents.
    Huang X; Shen QK; Zhang HJ; Li JL; Tian YS; Quan ZS
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30177642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.